Copertina

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Phillips, Rachael V., van der Laan, Mark J.
Natura:	Preprint
Pubblicazione:	2024
Soggetti:	Applications Methodology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
di: Qiu, Sky, et al.
Pubblicazione: (2025)

Practical considerations for specifying a super learner
di: Phillips, Rachael V., et al.
Pubblicazione: (2022)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
di: Qiu, Sky, et al.
Pubblicazione: (2026)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
di: Yang, Peng, et al.
Pubblicazione: (2026)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
di: Thomas, Owen, et al.
Pubblicazione: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
di: Sokolova, Alexandra, et al.
Pubblicazione: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
di: Maity, Arnab Kumar, et al.
Pubblicazione: (2024)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
di: Mao, Guangcai, et al.
Pubblicazione: (2025)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
di: Lotspeich, Sarah C., et al.
Pubblicazione: (2026)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
di: Zhang, Cong, et al.
Pubblicazione: (2026)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
di: Wang, Sidi, et al.
Pubblicazione: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
di: Komaki, Moka, et al.
Pubblicazione: (2025)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
di: Sunami, Hisato, et al.
Pubblicazione: (2024)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
di: Ouyang, Yongdong, et al.
Pubblicazione: (2024)

Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
di: Qiu, Sky, et al.
Pubblicazione: (2026)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
di: Pramanik, Paramahansa, et al.
Pubblicazione: (2026)

HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
di: Shi, Junming, et al.
Pubblicazione: (2024)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
di: Chassat, Perrine, et al.
Pubblicazione: (2025)

Bayesian defective Marshall-Olkin Gompertz model: an integrated approach to identifying cure fraction
di: Alves-Neto, Dionisio, et al.
Pubblicazione: (2024)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
di: Yuan, Shijie, et al.
Pubblicazione: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
di: Zhu, Di, et al.
Pubblicazione: (2026)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
di: Lee, Jooyeon, et al.
Pubblicazione: (2025)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
di: Jobson, Deddy, et al.
Pubblicazione: (2024)

Cost Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials
di: Montoya, Lina M., et al.
Pubblicazione: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
di: Zhang, Hong, et al.
Pubblicazione: (2023)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
di: Zhao, Yao, et al.
Pubblicazione: (2026)

A Causal Machine Learning Framework for Treatment Personalization in Clinical Trials: Application to Ulcerative Colitis
di: Minoccheri, Cristian, et al.
Pubblicazione: (2026)

Simulation-Guided Planning of a Target Trial Emulated Cluster Randomized Trial for Mass Small-Quantity Lipid Nutrient Supplementation Combined with Expanded Program on Immunization in Rural Niger
di: Alam, Shomoita, et al.
Pubblicazione: (2025)

A Bayesian Framework for Latent Compliance Modeling in Cluster Randomized Trials with One-Sided Noncompliance
di: Sisti, Anthony, et al.
Pubblicazione: (2025)

Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
di: Tu, Shengxin, et al.
Pubblicazione: (2025)

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials
di: Zhao, Xianglin, et al.
Pubblicazione: (2025)

TAD-SIE: Sample Size Estimation for Clinical Randomized Controlled Trials using a Trend-Adaptive Design with a Synthetic-Intervention-Based Estimator
di: Lala, Sayeri, et al.
Pubblicazione: (2024)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
di: Zhang, Fanni, et al.
Pubblicazione: (2025)

Implementing Response-Adaptive Randomisation in Stratified Rare-disease Trials: Design Challenges and Practical Solutions
di: Das, Rajenki, et al.
Pubblicazione: (2024)

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties
di: Cui, Ying, et al.
Pubblicazione: (2025)

Mixture of Finite Mixtures Model for Basket Trial
di: Geng, Junxian, et al.
Pubblicazione: (2020)

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials
di: Balzer, Laura B., et al.
Pubblicazione: (2022)

A Clinical Instrument to Measure Patient Anecdotes in Clinical Trials
di: Miller, Ian, et al.
Pubblicazione: (2025)

Comparison of Simulation-Guided Design to Closed-Form Power Calculations in Planning a Cluster Randomized Trial with Covariate-Constrained Randomization: A Case Study in Rural Chad
di: Park, Jay JH, et al.
Pubblicazione: (2025)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
di: Golchi, Shirin, et al.
Pubblicazione: (2026)